Mönchspfeffer

Niedenthal, Tobias; Puchtler, Elke

doi:10.1055/a-1841-4395

Cited by 1 publication

(1 citation statement)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In this context, herbal medicines (HMs) could constitute a signi cant alternative treatment option solving many of these problems. For the treatment of menstrual complaints extracts of chaste tree have shown considerable e ciency in a variety of clinical studies (30) being even superior to placebo (31,32) and potent in reducing signs of headache, irritability or breast tension (33). The standardized extracts of black cohosh can be used for the treatment of menopausal ailments as evidenced by several clinical studies (34)(35)(36).…”

Section: Introductionmentioning

confidence: 99%

Patient-reported Therapeutic Benefits of Herbal Medicines in the Treatment of Gynecological Ailments

Drebka,

Scholl,

Ochs

et al. 2024

Preprint

View full text Add to dashboard Cite

Background: Gynaecological ailments have a negative impact on quality of life and productivity. Standard treatment is associated with poor tolerability and other issues related to public health and environment. Herbal Medicines (HMs) are used traditionally for the treatment of menstrual and menopausal ailments as well as uncomplicated urinary tract infections for centuries and constitute an excellent addition to current treatment options. HMs are well tolerated, non-polluting and therapeutically efficacious as evidenced by various clinical studies. Aim of this study was to expand the evidence regarding therapeutic efficacy of HMs for the treatment of gynaecological complaints by complementing knowledge from clinical studies with real world evidence from patient reported outcomes. Methods: We applied descriptive statistical methods and analyzed a data sample taken from the pharmaco-epidemiological database PhytoVIS regarding frequency and percentage. Thereafter we evaluated the therapeutic benefit of herbal medicines (HMs) in gynaecological complaints as well as side effects. Results: More than 80% of the patients in the sample assessed the overall therapeutic benefit of HMs for the treatment of gynaecological complaints as very positive. Over 90% of the patients using HMs perceived no or no significant side effects. Treatment habits differed depending on the type of complaint. In this context the majority of women with menstrual or menopausal ailments preferred to treat for time period of 1 month or longer, while those affected by uncomplicated urinary tract infections reduced the application of HMs to the length of their symptoms. Interestingly women with even strong symptoms relied on the therapeutic benefit of HMs. Conclusion: Real-world outcome data are an important supplement to clinical data. Our results reveal the excellent benefit-risk ratio of HMs and help to implement them into novel therapeutic strategies to treat gynaecological complaints.

show abstract